Helicobacter Pylori and Gastric Cancer: Factors That Modulate Disease Risk

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2010 Oct 9

PMID 20930071

Citations 618

Authors

Lydia E Wroblewski

Richard M Peek Jr

Keith T Wilson

Affiliations

Soon will be listed here.

Abstract

Helicobacter pylori is a gastric pathogen that colonizes approximately 50% of the world's population. Infection with H. pylori causes chronic inflammation and significantly increases the risk of developing duodenal and gastric ulcer disease and gastric cancer. Infection with H. pylori is the strongest known risk factor for gastric cancer, which is the second leading cause of cancer-related deaths worldwide. Once H. pylori colonizes the gastric environment, it persists for the lifetime of the host, suggesting that the host immune response is ineffective in clearing this bacterium. In this review, we discuss the host immune response and examine other host factors that increase the pathogenic potential of this bacterium, including host polymorphisms, alterations to the apical-junctional complex, and the effects of environmental factors. In addition to host effects and responses, H. pylori strains are genetically diverse. We discuss the main virulence determinants in H. pylori strains and the correlation between these and the diverse clinical outcomes following H. pylori infection. Since H. pylori inhibits the gastric epithelium of half of the world, it is crucial that we continue to gain understanding of host and microbial factors that increase the risk of developing more severe clinical outcomes.

Citing Articles

Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori.

Kamali N, Talebi Bezmin Abadi A, Rahimi F, Forootan M BMC Res Notes. 2025; 18(1):109.

PMID: 40069707 PMC: 11899000. DOI: 10.1186/s13104-025-07165-8.

Vacuolating Cytotoxin A (VacA) and Extracellular Vesicles in : Two Key Arms in Disease Development.

Alavi Rostami S, Khaledi M, Dalilian F, Mehboodi M, Akbari A, Shahini Shams Abadi M Iran J Pathol. 2025; 20(1):1-17.

PMID: 40060221 PMC: 11887638. DOI: 10.30699/ijp.2024.2031417.3312.

The Prebiotic Effect of Kaempferol in Regulating Bile Acid Metabolism.

Li X, Huang G, Khan I, Ding Z, Hsiao W, Liu Z Food Sci Nutr. 2025; 13(3):e70023.

PMID: 40008236 PMC: 11848346. DOI: 10.1002/fsn3.70023.

Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.

Lu D, Ma X, Tao K, Lei H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996827 PMC: 11853859. DOI: 10.3390/cimb47020106.

Initial Diagnostic Strategies for Helicobacter Pylori in Patients With Bleeding Peptic Ulcers Undergoing Endoscopy: A Cost-Effectiveness Analysis.

Artin M, Soddano J, Rustgi S, Aziz Z, Lim F, Yang J Gastro Hep Adv. 2025; 4(4):100602.

PMID: 39996244 PMC: 11849076. DOI: 10.1016/j.gastha.2024.100602.

References

Oliveira M, Costa A, Costa A, Ferreira R, Sampaio P, Machado J . CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J Infect Dis. 2009; 200(5):745-55. DOI: 10.1086/604727. View

Wong B, Wang W, So W, Shin V, Wong W, Fung F . Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment Pharmacol Ther. 2001; 15(9):1459-65. DOI: 10.1046/j.1365-2036.2001.01051.x. View

Pathak S, Basu S, Bhattacharyya A, Pathak S, Banerjee A, Basu J . TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from.... J Immunol. 2006; 177(11):7950-8. DOI: 10.4049/jimmunol.177.11.7950. View

Bamford K, Fan X, Crowe S, Leary J, Gourley W, Luthra G . Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 1998; 114(3):482-92. DOI: 10.1016/s0016-5085(98)70531-1. View

Azevedo M, Eriksson S, Mendes N, Serpa J, Figueiredo C, Resende L . Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol. 2008; 215(3):308-16. DOI: 10.1002/path.2363. View

Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View

Kavermann H, Burns B, Angermuller K, Odenbreit S, Fischer W, Melchers K . Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med. 2003; 197(7):813-22. PMC: 2193887. DOI: 10.1084/jem.20021531. View

Kirschner D, Blaser M . The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol. 1995; 176(2):281-90. DOI: 10.1006/jtbi.1995.0198. View

Whary M, Sundina N, Bravo L, Correa P, Quinones F, Caro F . Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2005; 14(6):1464-9. DOI: 10.1158/1055-9965.EPI-05-0095. View

10.

Aspholm M, Olfat F, Norden J, Sonden B, Lundberg C, Sjostrom R . SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2006; 2(10):e110. PMC: 1626103. DOI: 10.1371/journal.ppat.0020110. View

11.

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

12.

Forte J, Yao X . The membrane-recruitment-and-recycling hypothesis of gastric HCl secretion. Trends Cell Biol. 1996; 6(2):45-8. DOI: 10.1016/0962-8924(96)81009-9. View

13.

Hirasawa R, Tatsuta M, Iishi H, Yano H, Baba M, Uedo N . Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am J Gastroenterol. 1999; 94(9):2398-402. DOI: 10.1111/j.1572-0241.1999.01350.x. View

14.

Mayerle J, Friess H, Buchler M, Schnekenburger J, Weiss F, Zimmer K . Up-regulation, nuclear import, and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer. Gastroenterology. 2003; 124(4):949-60. DOI: 10.1053/gast.2003.50142. View

15.

Hellmig S, Ott S, Rosenstiel P, Folsch U, Hampe J, Schreiber S . Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection. Am J Gastroenterol. 2006; 101(1):29-35. DOI: 10.1111/j.1572-0241.2005.00348.x. View

16.

Houghton J, Stoicov C, Nomura S, Rogers A, Carlson J, Li H . Gastric cancer originating from bone marrow-derived cells. Science. 2004; 306(5701):1568-71. DOI: 10.1126/science.1099513. View

17.

Parsonnet J, Friedman G, ORENTREICH N, Vogelman H . Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997; 40(3):297-301. PMC: 1027076. DOI: 10.1136/gut.40.3.297. View

18.

Wilson K, Ramanujam K, Mobley H, Musselman R, James S, Meltzer S . Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology. 1996; 111(6):1524-33. DOI: 10.1016/s0016-5085(96)70014-8. View

19.

Ruzsovics A, Unger Z, Molnar B, Pronai L, Tulassay Z . Effect of Helicobacter pylori infection on epidermal growth factor receptor (EGFR) expression and cell proliferation of gastric epithelial mucosa: correlation to macroscopic and microscopic diagnosis. Int J Exp Pathol. 2003; 83(5):257-63. PMC: 2517688. DOI: 10.1046/j.1365-2613.2002.00234.x. View

20.

Wagner S, Beil W, Westermann J, Logan R, Bock C, Trautwein C . Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology. 1997; 113(6):1836-47. DOI: 10.1016/s0016-5085(97)70003-9. View